Skip to main content

Table 1 Clinical and biochemical characteristics of T1D patients

From: Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an observational study

Variable T1D without AT and CD T1D with AT and or CD p
Number 69 41
Age (y) 38 ± 13 35 ± 14 0.34
Gender (Female %) 39 61 0.02
Disease duration (y) 16 ± 9 18 ± 10 0.33
Age at the onset of diabetes (y) 21 ± 13 16 ± 12 0.09
HbA1c (%) 7.8 ± 1.2 7.6 ± 0.8 0.34
FPG (mg/dL) 162 ± 68 136 ± 67 0.09
Body weight (kg) 74 ± 12 69 ± 14 0.06
Waist (cm) 91 ± 11 89 ± 14 0.51
BMI (kg/m2) 26 ± 4 25 ± 5 0.26
Total cholesterol (mg/dL) 170 ± 34 165 ± 26 0.34
Triglycerides (mg/dL) 91 ± 53 67 ± 24 0.05
HDL-cholesterol (mg/dL) 57 ± 13 62 ± 13 0.11
LDL-cholesterol (mg/dL) 95 ± 32 89 ± 21 0.33
SBP (mmHg) 130 ± 20 131 ± 16 0.69
DBP (mmHg) 74 ± 10 75 ± 10 0.81
HR (bpm) 73 ± 12 77 ± 20 0.24
CSII (%) 35 56 0.02
CGM (%) 42 48 0.31
Hypertension (%) 14 12 0.49
Hyperlipidemia (%) 22 7 0.04
Retinopathy (%) 21 17 0.37
Nephropathy (%) 9 5 0.37
Neuropathy (%) 12 14 0.43
Macroangiopathy (%) 0 0 1
  1. Data are mean ± SD and percentage
  2. AT autoimmune thyroiditis, CD celiac disease, HbA1c glycated hemoglobin, FPG fasting plasma glucose, BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, CSII continuous subcutaneous insulin infusion, CGM continuous glucose monitoring